Non-random relations in drug use expressed as patterns comprising prescription and over-the-counter drugs in multimorbid elderly patients in primary care: Data of the exploratory analysis of the multicentre, observational cohort study MultiCare

References

• 13. koordinierte Bevölkerungsvorausberechnung [Internet]. [cited 2016 Nov 25]. Available from: https://www.destatis.de/bevoelkerungspyramide/#!y=2020.
   Google Scholar
• Fortin M, Stewart M, Poitras M-E, et al. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10:142–151.
   PubMed Web of Science ®Google Scholar
• Masnoon N, Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;10:17.
   Google Scholar
• Strehblow C, Smeikal M, Fasching P. Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients. Wien Klin Wochenschr. 2014;126:195–200.
   PubMed Web of Science ®Google Scholar
• Maher RL, Hanlon JT, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.
   PubMed Web of Science ®Google Scholar
• Marengoni A, Onder G. Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. Br Med J. 2015;350(4):h1059.
   PubMed Web of Science ®Google Scholar
• Lee EA, Brettler JW, Kanter MH, et al. Refining the definition of polypharmacy and its link to disability in older adults: conceptualizing necessary polypharmacy, unnecessary polypharmacy, and polypharmacy of unclear benefit. Perm J. 2019;24:18.212.
   PubMedGoogle Scholar
• Lopez-Rodriguez JA, Rogero-Blanco E, Aza-Pascual-Salcedo M, et al. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: a cross-sectional study. PLoS One. 2020;15:e0237186.
   PubMed Web of Science ®Google Scholar
• George C, Verghese J. Polypharmacy and gait performance in community dwelling older adults. J Am Geriatr Soc. 2017;65(9):2082–2087.
   PubMed Web of Science ®Google Scholar
• Wickop B, Härterich S, Sommer C, et al. Potentially inappropriate medication use in multimorbid elderly inpatients: differences between the FORTA, PRISCUS and STOPP ratings. Drugs Real World Outcomes. 2016;3:317–325.
   PubMedGoogle Scholar
• Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. New Engl J Med. 2004;351:2870–2874.
   PubMed Web of Science ®Google Scholar
• Schäfer I, Hansen H, Schön G, et al. The German MultiCare-study: patterns of multimorbidity in primary health care – protocol of a prospective cohort study. BMC Health Serv Res. 2009;9:145.
   PubMed Web of Science ®Google Scholar
• Schäfer I, Hansen H, Schön G, et al. The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the MultiCare cohort study. BMC Health Serv Res. 2012;12:89.
   PubMed Web of Science ®Google Scholar
• Calderón-Larrañaga A, Gimeno-Feliu LA, González-Rubio F, et al. Polypharmacy patterns: unravelling systematic associations between prescribed medications. PLoS One. 2017;8(12):e84967.
   Web of Science ®Google Scholar
• Nathan A, Goodyer L, Lovejoy A, et al. “Brown bag” medication reviews as a means of optimizing patients’ use of medication and of identifying potential clinical problems. Fam Pract. 1999;16(3):278–282.
   PubMed Web of Science ®Google Scholar
• DIMDI – ATC/DDD Anatomisch-therapeutisch-chemische Klassifikation mit definierten Tagesdosen [Internet]. [cited 2017 Jul 20]. Available from: http://www.dimdi.de/static/de/klassi/atcddd/index.htm.
   Google Scholar
• AMG – Gesetz über den Verkehr mit Arzneimitteln [Internet]. [cited 2020 Dec 10]. Available from: https://www.gesetze-im-internet.de/amg_1976/BJNR024480976.html.
   Google Scholar
• Prados-Torres A, Poblador-Plou B, Calderón-Larrañaga A, et al. Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One. 2012;7:e32190.
   PubMed Web of Science ®Google Scholar
• Schäfer I, von Leitner E-C, Schön G, et al. Multimorbidity patterns in the elderly: a new approach of disease clustering identifies complex interrelations between chronic conditions. PLoS One. 2010;5:e15941.
   PubMed Web of Science ®Google Scholar
• Costello AB, Osborne JW. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval. 2005;10:1–9.
   Google Scholar
• Linsky A, Simon SR, Stolzmann K, et al. Patient perceptions of deprescribing: survey development and psychometric assessment. Med Care. 2017;55:306–313.
   PubMed Web of Science ®Google Scholar
• Weinbrenner S, Langer T, Scherer M, et al. Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz. Dtsch Med Wochenschr. 2012;137(05):219–127.
   PubMed Web of Science ®Google Scholar
• Ezekowitz JA, O’Meara E, McDonald MA, et al. 2017 Comprehensive update of the Canadian cardiovascular society guidelines for the management of heart failure. Can J Cardiol. 2017;33:1342–1433.
   PubMed Web of Science ®Google Scholar
• Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933–989.
   PubMed Web of Science ®Google Scholar
• Bruderer S, Bodmer M, Jick SS, et al. Use of diuretics and risk of incident gout: a population-based case–control study. Arthritis Rheumatol. 2014;66:185–196.
   PubMed Web of Science ®Google Scholar
• Díez-Manglano J, Giménez-López M, Garcés-Horna V, et al. Excessive polypharmacy and survival in polypathological patients. Eur J Clin Pharmacol. 2015;71:733–739.
   PubMed Web of Science ®Google Scholar
• Villanyi D, Fok M, Wong RYM. Medication reconciliation: identifying medication discrepancies in acutely ill hospitalized older adults. Am J Geriatr Pharmacother. 2011;9:339–344.
   PubMed Web of Science ®Google Scholar
• Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. J Am Med Assoc. 2008;300:2867–2878.
   PubMed Web of Science ®Google Scholar
• Barrenberg E, Garbe E. Use of over-the-counter (OTC) drugs and perceptions of OTC drug safety among German adults. Eur J Clin Pharmacol. 2015;71:1389–1396.
   PubMed Web of Science ®Google Scholar
• Barnett K, McCowan C, Evans JMM, et al. Prevalence and outcomes of use of potentially inappropriate medicines in older people: cohort study stratified by residence in nursing home or in the community. BMJ Qual Saf. 2011;20:275–281.
   PubMed Web of Science ®Google Scholar
• Menditto E, Gimeno Miguel A, Moreno Juste A, et al. Patterns of multimorbidity and polypharmacy in young and adult population: systematic associations among chronic diseases and drugs using factor analysis. PLoS One. 2019;14:e0210701.
   PubMed Web of Science ®Google Scholar